Dana-Farber Cancer Institute

308 articles about Dana-Farber Cancer Institute

• Molecular Imaging Corporation Enters Relationship with Dana-Farber Cancer Institute to Expand Luciferase-reporter Cancer Cell Lines for Preclinical in vivo Imaging

  12/14/2011

• Dana-Farber Cancer Institute Launches Cancer Blog

  12/14/2011

• Prostate Cancer Hormonal Therapy Cuts Deaths, Dana-Farber Cancer Institute and Brigham and Women's Hospital Study

  12/7/2011

• Prostate Cancer Drugs Aren’t Tied to Heart Attacks, Dana-Farber Cancer Institute Study

  12/7/2011

• MD Anderson Has Hired Away 55 Scientists from Dana-Farber Cancer Institute

  12/6/2011

• Colon Cancer Prognosis Worse for the Obese, Type 2 Diabetics, Harvard Medical School and Dana-Farber Cancer Institute Study

  12/5/2011

• Drug May Dampen Dangerous Side Effect of Stem Cell Transplants, Dana-Farber Cancer Institute Study

  12/1/2011

• Cellceutix Files Investigational New Drug Application (IND) With FDA, Clinical Trials Planned at Dana-Farber Cancer Institute/Harvard Cancer Center

  11/7/2011

• Predicting How Cancers Will Respond to Chemo: New Test Determines Whether Tumor Cells Are Already 'Primed' for Death, Dana-Farber Cancer Institute Study

  10/31/2011

• Dana-Farber Cancer Institute, Brigham and Women's Hospital’s Launch Profile, a Large-Scale Research Program to Scan Tumors for Mutations, Establish Extensive Genomic Database

  10/26/2011

• Fetal Hemoglobin Production Reverses Sickle Cell Anemia, Dana-Farber Cancer Institute Study

  10/14/2011

• Dana-Farber Cancer Institute Slams New Prostate-Cancer Test Guidelines

  10/10/2011

• Cellceutix Signs Lab Services Research Support Agreement With Dana-Farber Cancer Institute/Partners CancerCare, Inc.

  9/21/2011

• AbD Serotec Signs Agreement with Dana-Farber Cancer Institute for Anti- Infective Research

  7/25/2011

• Blocking Molecular Target Could Make More Cancers Treatable With PARP Inhibitors, Dana-Farber Cancer Institute Study

  6/30/2011

• Cancer Patients Help Redesign Dana-Farber Cancer Institute’s Website

  5/19/2011

• Promising Target for AIDS Vaccine, Dana-Farber Cancer Institute Study Reveals

  4/1/2011

• Transgenomic, Inc. Expands COLD-PCR License with Dana-Farber Cancer Institute

  3/15/2011

• Aspirin May Protect Against Colorectal Cancer -- But Only in Certain People, Massachusetts General Hospital and Dana-Farber Cancer Institute Study

  3/14/2011

• Dana-Farber Cancer Institute Selects CLC bio's Enterprise Platform

  3/8/2011